METHYLENE BLUE INHIBITS THE INTERACTION BETWEEN HEPARAN SULFATE AND SARS-COV-2 SPIKE PROTEIN; A REVIEW OF EVIDENCE FOR A HYPOTHESIS.

Authors

  • Neluwa-Liyanage Ruwan Indika Department of Biochemistry, Faculty of Medical Sciences, University of Sri Jayewardenepura, Nugegoda, Sri Lanka.
  • Nirmalie Gayathrie Fonseka National Blood Centre, Colombo 05, Sri Lanka

Abstract

The addition of methylene blue to the standard treatment protocol has been shown to improve respiratory rate and oxygen saturation in COVID-19 patients, reducing morbidity and mortality. Evidence to date suggests that methylene blue inhibits protein-protein interactions between SARS-CoV-2 Spike protein and angiotensin-converting enzyme 2, which in turn inhibits the cell entry of SARS-CoV-2. However, the methylene blue dye-binding characteristics of sulfated glycosaminoglycans suggest additional inhibitory effects of the spike protein-heparan sulfate interaction. We hypothesize that the binding of cationic methylene blue neutralizes polyanionic heparan sulfate molecules on the host cell surface. As a consequence, electrostatic interactions between negatively charged heparan sulfate and the positively charged receptor binding domain of SARS-CoV-2 spike protein will be inhibited. Thus, methylene blue will exhibit a "shielding effect" on the heparan sulfate proteoglycans, inhibiting viral attachment to the cell surface. The proposed mechanism corroborates the possible broad-spectrum antiviral activity of methylene blue against multiple human coronaviruses that exploit the electrostatic interactions with sulfated glycosaminoglycans for virus entry. Methylene blue would exhibit the same anti-adhesive activity at the blood-brain-barrier and olfactory neuroepithelium, corroborating potential benefits in ameliorating post-COVID-19 neurological impairment. However, as cationic dyes can bind to both free glycosaminoglycans in circulation as well as proteoglycans attached to the cell surface, co-administration of intravenous heparin could possibly antagonize the proposed antiviral activity. This critical review focuses on empirical evidence to support the hypothesized heparan sulfate-dependent antiviral activity of MB.

Keywords:

Methylene blue, SARS-CoV-2, COVID-19, Heparan sulfate, Proteoglycans, Antiviral

Downloads

Download data is not yet available.

References

Aquino, R. S., & Park, P. W. (2016). Glycosaminoglycans and infection. Front Biosci (Landmark Ed), 21, 1260-1277. https://fbscience.com/Landmark/articles/10.2741/4455

Berry, H. K. (1987). Screening for mucopolysaccharide disorders with the Berry spot test. Clinical Biochemistry, 20(5), 365-371. https://doi.org/10.1016/S0009-9120(87)80088-7

Bistas, E., & Sanghavi, D. J. S. (2020). Methylene blue. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; Available from: https://www.ncbi.nlm.nih.gov/books/NBK557593/

Bobardt, M. D., Salmon, P., Wang, L., Esko, J. D., Gabuzda, D., Fiala, M., . . . Gallay, P. A. (2004). Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion. Journal of Virology, 78(12), 6567-6584. https://doi.org/10.1128/JVI.78.12.6567-6584.2004

Bojadzic, D., Alcazar, O., & Buchwald, P. (2020). Methylene Blue Inhibits the SARS-CoV-2 Spike-ACE2 Protein-Protein Interaction-a Mechanism that can Contribute to its Antiviral Activity Against COVID-19. Frontiers in Pharmacology, 11, 600372. https://doi.org/10.3389/fphar.2020.600372

Bojadzic, D., Alcazar, O., Chen, J., Chuang, S. T., Condor Capcha, J. M., Shehadeh, L. A., & Buchwald, P. (2021). Small-Molecule Inhibitors of the Coronavirus Spike: ACE2 Protein-Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2. ACS Infect Dis, 7(6), 1519-1534. https://doi.org/10.1021/acsinfecdis.1c00070

Clausen, T. M., Sandoval, D. R., Spliid, C. B., Pihl, J., Perrett, H. R., Painter, C. D., . . . Esko, J. D. (2020). SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2. Cell, 183(4), 1043-1057.e1015. https://doi.org/10.1016/j.cell.2020.09.033

Dey, P. (2018). Staining Principle and general procedure of staining of the tissue. In Basic and Advanced Laboratory Techniques in Histopathology and Cytology (pp. 57-67): Springer. https://doi.org/10.1007/978-981-10-8252-8_7

Ghahestani, S. M., Shahab, E., Karimi, S., & Madani, M. H. (2020). Methylene blue may have a role in the treatment of COVID-19. Medical Hypotheses, 144, 110163. https://doi.org/10.1016/j.mehy.2020.110163

Ginimuge, P. R., & Jyothi, S. D. (2010). Methylene blue: revisited. Journal of Anaesthesiology, Clinical Pharmacology, 26(4), 517-520. https://www.joacp.org/article.asp?issn=0970-9185;year=2010;volume=26;issue=4;spage=517;epage=520;aulast=Ginimuge

Hamidi-Alamdari, D., Hafizi-Lotfabadi, S., Bagheri-Moghaddam, A., Safari, H., Mozdourian, M., Javidarabshahi, Z., . . . Koliakos, G. (2021). METHYLENE BLUE FOR TREATMENT OF HOSPITALIZED COVID-19 PATIENTS: A RANDOMIZED, CONTROLLED, OPEN-LABEL CLINICAL TRIAL, PHASE 2. Revista de Investigación Clínica, 73(3), 190-198. https://doi.org/10.24875/ric.21000028

Hassanzadeh, K., Perez Pena, H., Dragotto, J., Buccarello, L., Iorio, F., Pieraccini, S., . . . Feligioni, M. (2020). Considerations around the SARS-CoV-2 Spike Protein with Particular Attention to COVID-19 Brain Infection and Neurological Symptoms. ACS Chemical Neuroscience, 11(15), 2361-2369. https://doi.org/10.1021/acschemneuro.0c00373

Hu, Y., Meng, X., Zhang, F., Xiang, Y., & Wang, J. (2021). The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor. Emerg Microbes Infect, 10(1), 317-330. https://doi.org/10.1080/22221751.2021.1888660

Jiao, Q., & Liu, Q. (1999). Characterization of the interaction between methylene blue and glycosaminoglycans. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 55(7), 1667-1673. https://doi.org/10.1016/S1386-1425(98)00323-0

Kumar, A., Pareek, V., Prasoon, P., Faiq, M. A., Kumar, P., Kumari, C., & Narayan, R. K. (2020). Possible routes of SARS-CoV-2 invasion in brain: In context of neurological symptoms in COVID-19 patients. Journal of Neuroscience Research, 98(12), 2376-2383. https://doi.org/10.1002/jnr.24717

Magoon, R., Bansal, N., Singh, A., & Kashav, R. (2021). Methylene blue: Subduing the post COVID-19 blues! Medical Hypotheses, 150, 110574. https://doi.org/10.1016/j.mehy.2021.110574

Milewska, A., Zarebski, M., Nowak, P., Stozek, K., Potempa, J., & Pyrc, K. (2014). Human coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cells. Journal of Virology, 88(22), 13221-13230. https://doi.org/10.1128/jvi.02078-14

Milho, R., Frederico, B., Efstathiou, S., & Stevenson, P. G. (2012). A heparan-dependent herpesvirus targets the olfactory neuroepithelium for host entry. PLoS Pathogens, 8(11), e1002986. https://doi.org/10.1371/journal.ppat.1002986

Scigliano, G., & Scigliano, G. A. (2021). Methylene blue in covid-19. Medical Hypotheses, 146, 110455. https://doi.org/10.1016/j.mehy.2020.110455

Soares da Costa, D., Reis, R. L., & Pashkuleva, I. (2017). Sulfation of Glycosaminoglycans and Its Implications in Human Health and Disorders. Annual Review of Biomedical Engineering, 19, 1-26. https://doi.org/10.1146/annurev-bioeng-071516-044610

Stone, J. E., Akhtar, N., Botchway, S., & Pennock, C. (1994). Interaction of 1, 9-dimethylmethylene blue with glycosaminoglycans. Annals of Clinical Biochemistry, 31(2), 147-152. https://doi.org/10.1177%2F000456329403100206

Templeton, D. M. (1988). The basis and applicability of the dimethylmethylene blue binding assay for sulfated glycosaminoglycans. Connective Tissue Research, 17(1), 23-32. https://doi.org/10.3109/03008208808992791

Yu, M., Zhang, T., Zhang, W., Sun, Q., Li, H., & Li, J.-p. (2021). Elucidating the Interactions Between Heparin/Heparan Sulfate and SARS-CoV-2-Related Proteins—An Important Strategy for Developing Novel Therapeutics for the COVID-19 Pandemic. 7(490). https://doi.org/10.3389/fmolb.2020.628551

Zhang, Q., Chen, C. Z., Swaroop, M., Xu, M., Wang, L., Lee, J., . . . Ye, Y. (2020). Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro. Cell Discov, 6(1), 80. https://doi.org/10.1038/s41421-020-00222-5

Published

2021-10-01

How to Cite

Neluwa-Liyanage Ruwan Indika, & Nirmalie Gayathrie Fonseka. (2021). METHYLENE BLUE INHIBITS THE INTERACTION BETWEEN HEPARAN SULFATE AND SARS-COV-2 SPIKE PROTEIN; A REVIEW OF EVIDENCE FOR A HYPOTHESIS. Malaysian Journal of Medical Research (MJMR), 5(4). Retrieved from https://ejournal.lucp.net/index.php/mjmr/article/view/1412